All News

2060 articles, sorted by publication time.

Biotech Industry · global

Roche Expands Hansoh ADC Partnership With $400 Million Upfront Payment, Building a Preclinical Cancer Drug Portfolio

The collaboration expands from a single drug to multiple early-stage programs, with Hansoh advancing them through global Phase Ia trials before Roche takes over development outside Greater China. More than $15 billion in potential milestone payments remains contingent on development, approval and commercialization outcomes.

Drug Development · global

More Evidence for Once-Daily Oral Treatment: Phase 2 Trial of Emvistegrast Improves Ulcerative Colitis Remission Rates

After 12 weeks of treatment, about three in ten patients in the 200 mg group achieved clinical remission, compared with 8% in the placebo group. The findings support advancing to Phase 3 trials, but questions remain about whether efficacy can be sustained and whether the results apply to more patients whose previous treatments have failed.